Skip to content

Analysis of salivary metabolism differences in people living with HIV/AIDS at different stages

Analysis of salivary metabolism differences in people living with HIV/AIDS at different stages

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059878
Enrollment
Unknown
Registered
2022-05-13
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Group after ART :Antiretroviraltherapy

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for healthy control group: (1) Aged over 18 years old; (2) The oral mucosa has no lesions and damage; (3) Whole body healthy HIV antibody-negative volunteers. 2. Inclusion criteria for HIV-infected patients: (1) The clinical confirmation test is positive for HIV antibody; (2) Aged over 18 years old; (3) No lesions and damage to the oral mucosa (except for pseudomembranous candidiasis); (4) HIV-positive patients in stages 0, 1, 2, and 3 did not receive ART; (5) Follow-up of PLWHA subjects: follow-up once after 3 months of ART treatment, to 6 months.

Exclusion criteria

Exclusion criteria: 1. Untreated cavities, caries lesions, oral abscesses, and missing 8 or more teeth due to various reasons. 2. Patients with mucosal lesions or damage other than pseudomembranous candidiasis in the oral cavity; 3. Those who have received ART or other treatments; 4. Glucocorticoids, immunosuppressants and antibiotics have been used within 3 months; 5. Patients with systemic diseases such as heart, liver, kidney, lung, diabetes, hypertension, and other immune system diseases; 6. Other tumors and mentally ill patients; 7. Those who did not sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Salivary metabolites;

Secondary

MeasureTime frame
CD4+T lymphocyte count;HIV blood viral load;

Countries

China

Contacts

Public ContactYing Guo

Beijing Youan Hospital, Capital Medical University

153505774@qq.com+86 010-83997245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026